260
Participants
Start Date
August 5, 2022
Primary Completion Date
February 1, 2023
Study Completion Date
May 4, 2023
XC221
200 mg/day, for 5 days
Placebo
2 tablets/day, for 5 days
Unimed-C Jsc, Moscow
"State budgetary institution of health care of the Yaroslavl region Clinical Hospital No. 2", Yaroslavl
"Limited Liability Company Health Energy", Saint Petersburg
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 117", Saint Petersburg
"Saint Petersburg State Budgetary Healthcare Institution City polyclinic No. 112", Saint Petersburg
"Limited Liability Company Research Center Eco-Security", Saint Petersburg
"Saint Petersburg State Budgetary Institution of Healthcare City Pokrovskaya Hospital", Saint Petersburg
"St. Petersburg State Budgetary Healthcare Institution City Polyclinic No. 4", Saint Petersburg
"Limited Liability Company Meili", Saint Petersburg
"State autonomous health care institution Engels City Clinical Hospital No. 1", Engel's
Professors' Clinic LLC., Perm
"Medical Diagnostic Center Medexpert, LLC", Engel's
"Medical Clinic Ltd.", Saint Petersburg
Valenta Pharm JSC
INDUSTRY